| Property | Value |
|
keywords
|
Adverse Drug Reactions to Antimicrobials
|
|
keywords
|
Antimicrobial Stewardship
|
|
keywords
|
Trends in Antimicrobial Utilization
|
|
research overview
|
Dr. Goldman is Professor of Pediatrics at the University of Missouri-Kansas City and a member of the Divisions of Clinical Pharmacology, Toxicology and Therapeutic Innovation and Infectious Diseases at Children’s Mercy Kansas City (CMKC). Both her research and clinical efforts are centered on working with people across disciplines to improve the lives of children. She serves as principal investigator (R01GM129783) on an interdisciplinary program evaluating the safety of medications in children and site PI for a multi-center program to optimize pediatric surgical perioperative antimicrobial use (PI Newland; R01HS0267420). Since the COVID-19 pandemic, much of her effort has focused on providing guidance to schools on local and regional levels across Kansas and Missouri. She serve as co-PI of School TLC, a NIH Rapid Acceleration of Diagnostic Testing Initiative (RADx-UP) award (1OT2HD107555-01 and 02). Through School TLC, the research team has successfully implemented COVID-19 screening and surveillance testing in a large, urban school district, enrolling more than 1,000 students and staff to date and performing nearly 3,000 SARS-CoV-2 tests. Serving as an expert on the Missouri Department of Education COVID-19 taskforce and as a team lead on the Missouri Chapter of the American Academy of Pediatrics COVID-19 & Kids ECHO, which is a weekly educational session offered to schools statewide to provide expert guidance, provide opportunities to stay up to date on the ever-changing landscape of COVID-19 and schools. She also participates in the NIH-funded ABC Science Collaborative led by Duke pairing scientists and physicians with schools and community leaders to help understand the most current and relevant COVID-19 information.
|